Treatment of Metabolic Alkalosis in Acute Exacerbations of Cystic Fibrosis

Clinical trial NCT00163852 · UNKNOWN

Trial details

NCT number: NCT00163852
Sponsor: Bayside Health
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2004-02-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.